The T cell repertoire-diversifying enzyme TSSP contributes to thymic selection of diabetogenic CD4 T cell specificities reactive to ChgA and IAPP autoantigens

Journal of Immunology

Volumn 195, Issue 5, 2015, Pages 1964-1973

  Viret, Christophe ^a,b,c,d   Mahiddine, Karim ^a,b,c,d   Baker, Rocky Lee ^e   Haskins, Kathryn ^e   Guerder, Sylvie ^a,b,c,d  

^a University of Toulouse III   (France)

^b CHU PURPAN   (France)

^c CNRS   (France)

^d UNIVERSITÉ PAUL SABATIER   (France)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AUTOANTIGEN; CHROMOGRANIN A; PROTEINASE; THYMUS SPECIFIC SERINE PROTEASE; UNCLASSIFIED DRUG; CHROMOGRANIN A, MOUSE; LYMPHOCYTE ANTIGEN RECEPTOR; PRSS16 PROTEIN, MOUSE; SERINE PROTEINASE;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL SELECTION; CELL SPECIFICITY; CONTROLLED STUDY; DIABETOGENESIS; ENZYME ACTIVITY; IMMUNOREACTIVITY; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE; THYMOCYTE; THYMUS; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; NONOBESE DIABETIC MOUSE; SCID MOUSE;

ANIMALS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHROMOGRANIN A; FLOW CYTOMETRY; ISLET AMYLOID POLYPEPTIDE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; RECEPTORS, ANTIGEN, T-CELL; SERINE ENDOPEPTIDASES; STROMAL CELLS; THYMOCYTES; THYMUS GLAND;

EID: 84940116849     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401683     Document Type: Article

References (54)

1. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291-297.
2. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13: 179-200.
3. Christianson, S. W., L. D. Shultz, and E. H. Leiter. 1993. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 42: 44-55.
4. Ikehara, S., H. Tanaka, T. Nakamura, F. Furukawa, S. Inoue, K. Sekita, J. Shimizu, Y. Hamashima, and R. A. Good. 1985. The influence of thymic abnormalities on the development of autoimmune diseases. Thymus 7: 25-36.
5. Like, A. A., L. Butler, R. M. Williams, M. C. Appel, E. J. Weringer, and A. A. Rossini. 1982. Spontaneous autoimmune diabetes mellitus in the BB rat. Diabetes 31(Suppl. 1 Pt. 2): 7-13.
6. Whalen, B. J., D. L. Greiner, J. P. Mordes, and A. A. Rossini. 1994. Adoptive transfer of autoimmune diabetes mellitus to athymic rats: synergy of CD4+ and CD8+ T cells and prevention by RT6+ T cells. J. Autoimmun. 7: 819-831.
7. DiLorenzo, T. P., R. T. Graser, T. Ono, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 1998. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95: 12538-12543.
8. Groen, H., F. Klatter, J. Pater, P. Nieuwenhuis, and J. Rozing. 2003. Temporary, but essential requirement of CD8+ T cells early in the pathogenesis of diabetes in BB rats as revealed by thymectomy and CD8 depletion. Clin. Dev. Immunol. 10: 141-151.
9. Marrack, P., and J. W. Kappler. 2012. Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases? Cold Spring Harb. Perspect. Med. 2: a007765.
10. Bowlus, C. L., J. Ahn, T. Chu, and J. R. Gruen. 1999. Cloning of a novel MHC-encoded serine peptidase highly expressed by cortical epithelial cells of the thymus. Cell. Immunol. 196: 80-86.
11. Carrier, A., C. Nguyen, G. Victorero, S. Granjeaud, D. Rocha, K. Bernard, A. Miazek, P. Ferrier, M. Malissen, P. Naquet, et al. 1999. Differential gene expression in CD3epsilon- and RAG1-deficient thymuses: definition of a set of genes potentially involved in thymocyte maturation. Immunogenetics 50: 255-270.
12. Viret, C., S. Leung-Theung-Long, L. Serre, C. Lamare, D. A. Vignali, B. Malissen, A. Carrier, and S. Guerder. 2011. Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice. J. Clin. Invest. 121: 1810-1821.
13. Guerder, S., C. Viret, H. Luche, L. Ardouin, and B. Malissen. 2012. Differential processing of self-antigens by subsets of thymic stromal cells. Curr. Opin. Immunol. 24: 99-104.
14. Gommeaux, J., C. Grégoire, P. Nguessan, M. Richelme, M. Malissen, S. Guerder, B. Malissen, and A. Carrier. 2009. Thymus-specific serine protease regulates positive selection of a subset of CD4+ thymocytes. Eur. J. Immunol. 39: 956-964.
15. Viret, C., C. Lamare, M. Guiraud, N. Fazilleau, A. Bour, B. Malissen, A. Carrier, and S. Guerder. 2011. Thymus-specific serine protease contributes to the diversification of the functional endogenous CD4 T cell receptor repertoire. J. Exp. Med. 208: 3-11.
16. Lie, B. A., J. A. Todd, F. Pociot, J. Nerup, H. E. Akselsen, G. Joner, K. Dahl-Jørgensen, K. S. Rønningen, E. Thorsby, and D. E. Undlien. 1999. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am. J. Hum. Genet. 64: 793-800.
17. Lie, B. A., M. K. Viken, H. E. Akselsen, S. T. Flåm, F. Pociot, J. Nerup, I. Kockum, A. Cambon-Thomsen, E. Thorsby, and D. E. Undlien. 2007. Association analysis in type 1 diabetes of the PRSS16 gene encoding a thymus-specific serine protease. Hum. Immunol. 68: 592-598.
18. Viken, M. K., A. Blomhoff, M. Olsson, H. E. Akselsen, F. Pociot, J. Nerup, I. Kockum, A. Cambon-Thomsen, E. Thorsby, D. E. Undlien, and B. A. Lie. 2009. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun. 10: 323-333.
19. Haskins, K., M. Portas, B. Bradley, D. Wegmann, and K. Lafferty. 1988. T-lymphocyte clone specific for pancreatic islet antigen. Diabetes 37: 1444-1448.
20. Haskins, K., M. Portas, B. Bergman, K. Lafferty, and B. Bradley. 1989. Pancreatic islet-specific T-cell clones from nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 86: 8000-8004.
21. Haskins, K., and M. McDuffie. 1990. Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249: 1433-1436.
22. Haskins, K. 2005. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv. Immunol. 87: 123-162.
23. Burton, A. R., E. Vincent, P. Y. Arnold, G. P. Lennon, M. Smeltzer, C. S. Li, K. Haskins, J. Hutton, R. M. Tisch, E. E. Sercarz, et al. 2008. On the pathogenicity of autoantigen-specific T-cell receptors. Diabetes 57: 1321-1330.
24. Pauza, M. E., C. M. Dobbs, J. He, T. Patterson, S. Wagner, B. S. Anobile, B. J. Bradley, D. Lo, and K. Haskins. 2004. T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes 53: 978-988.
25. Stadinski, B. D., T. Delong, N. Reisdorph, R. Reisdorph, R. L. Powell, M. Armstrong, J. D. Piganelli, G. Barbour, B. Bradley, F. Crawford, et al. 2010. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 11: 225-231.
26. Nikoopour, E., C. Sandrock, K. Huszarik, O. Krougly, E. Lee-Chan, E. L. Masteller, J. A. Bluestone, and B. Singh. 2011. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice. J. Immunol. 186: 3831-3835.
27. Delong, T., R. L. Baker, N. Reisdorph, R. Reisdorph, R. L. Powell, M. Armstrong, G. Barbour, B. Bradley, and K. Haskins. 2011. Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells. Diabetes 60: 2325-2330.
28. Peterson, J. D., and K. Haskins. 1996. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells. Diabetes 45: 328-336.
29. Dallas-Pedretti, A., M. McDuffie, and K. Haskins. 1995. A diabetes-associated T-cell autoantigen maps to a telomeric locus on mouse chromosome 6. Proc. Natl. Acad. Sci. USA 92: 1386-1390.
30. Delong, T., R. L. Baker, J. He, G. Barbour, B. Bradley, and K. Haskins. 2012. Diabetogenic T-cell clones recognize an altered peptide of chromogranin A. Diabetes 61: 3239-3246.
31. Katz, J. D., B. Wang, K. Haskins, C. Benoist, and D. Mathis. 1993. Following a diabetogenic T cell from genesis through pathogenesis. Cell 74: 1089-1100.
32. Holst, J., A. L. Szymczak-Workman, K. M. Vignali, A. R. Burton, C. J.Workman, and D. A. Vignali. 2006. Generation of T-cell receptor retrogenic mice. Nat. Protoc. 1: 406-417.
33. Viret, C., C. Cresson, C. Broccardo, and S. Guerder. 2012. Retroviral transduction of lineage antigen-negative (Lin-) cells: a valuable alternative for the generation of T cell receptor (TCR) retrogenic mice. J. Immunol. Methods 384: 103-110.
34. Bergman, B., J. L. McManaman, and K. Haskins. 2000. Biochemical characterization of a beta cell membrane fraction antigenic for autoreactive T cell clones. J. Autoimmun. 14: 343-351.
35. Merkenschlager, M., M. O. Power, H. Pircher, and A. G. Fisher. 1999. Intrathymic deletion of MHC class I-restricted cytotoxic T cell precursors by constitutive cross-presentation of exogenous antigen. Eur. J. Immunol. 29: 1477-1486.
36. Suri, A., J. J. Walters, H. W. Rohrs, M. L. Gross, and E. R. Unanue. 2008. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules. J. Immunol. 180: 3849-3856.
37. Holst, J., K. M. Vignali, A. R. Burton, and D. A. Vignali. 2006. Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nat. Methods 3: 191-197.
38. Arnold, P. Y., A. R. Burton, and D. A. Vignali. 2004. Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic nonobese diabetic mice: generation by retroviral-mediated stem cell gene transfer. J. Immunol. 173: 3103-3111.
39. Zhang, L., J. M. Jasinski, M. Kobayashi, B. Davenport, K. Johnson, H. Davidson, M. Nakayama, K. Haskins, and G. S. Eisenbarth. 2009. Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4∗04 antiinsulin B:9-23 alpha chains. J. Autoimmun. 33: 42-49.
40. Azzam, H. S., A. Grinberg, K. Lui, H. Shen, E. W. Shores, and P. E. Love. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188: 2301-2311.
41. Serre, L., N. Fazilleau, and S. Guerder. 2015. Central tolerance spares the private high-avidity CD4+ T-cell repertoire specific for an islet antigen in NOD mice. Eur. J. Immunol. 45: 1946-1956.
42. Derbinski, J., A. Schulte, B. Kyewski, and L. Klein. 2001. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2: 1032-1039.
43. Koble, C., and B. Kyewski. 2009. The thymic medulla: a unique microenvironment for intercellular self-antigen transfer. J. Exp. Med. 206: 1505-1513.
44. Derbinski, J., J. Gäbler, B. Brors, S. Tierling, S. Jonnakuty, M. Hergenhahn, L. Peltonen, J. Walter, and B. Kyewski. 2005. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202: 33-45.
45. Ebert, P. J., S. Jiang, J. Xie, Q. J. Li, and M. M. Davis. 2009. An endogenous positively selecting peptide enhances mature T cell responses and becomes an autoantigen in the absence of microRNA miR-181a. Nat. Immunol. 10: 1162-1169.
46. Lo, W. L., N. J. Felix, J. J.Walters, H. Rohrs, M. L. Gross, and P. M. Allen. 2009. An endogenous peptide positively selects and augments the activation and survival of peripheral CD4+ T cells. Nat. Immunol. 10: 1155-1161.
47. DiLorenzo, T. P. 2011. Multiple antigens versus single major antigen in type 1 diabetes: arguing for multiple antigens. Diabetes Metab. Res. Rev. 27: 778-783.
48. Lundholm, M., V. Motta, A. Löfgren-Burström, N. Duarte, M. L. Bergman, S. Mayans, and D. Holmberg. 2006. Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1. Diabetes 55: 538-544.
49. Motta, V., K. Lejon, and D. Holmberg. 2007. The NOD allele of the Idd5 locus on chromosome 1 mediates a non-cell-autonomous defect in negative selection of T cells. J. Autoimmun. 28: 216-223.
50. Zucchelli, S., P. Holler, T. Yamagata, M. Roy, C. Benoist, and D. Mathis. 2005. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 22: 385-396.
51. Kishimoto, H., and J. Sprent. 2001. A defect in central tolerance in NOD mice. Nat. Immunol. 2: 1025-1031.
52. Lesage, S., S. B. Hartley, S. Akkaraju, J. Wilson, M. Townsend, and C. C. Goodnow. 2002. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J. Exp. Med. 196: 1175-1188.
53. Liston, A., S. Lesage, D. H. Gray, L. A. O'Reilly, A. Strasser, A. M. Fahrer, R. L. Boyd, J. Wilson, A. G. Baxter, E. M. Gallo, et al. 2004. Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21: 817-830.
54. Mingueneau, M., W. Jiang, M. Feuerer, D. Mathis, and C. Benoist. 2012. Thymic negative selection is functional in NOD mice. J. Exp. Med. 209: 623-637.